Date
27 January 2021
Infectious disease research ‘alarmingly low’
Gareth Willlmer of SciDevNet reports on the 2021 Access to Medicine Index finding about the lack of research for 10 of the 16 emerging diseases posing a pandemic risk in sharp contrast to the surge in R&D for COVID-19.
Gareth highlights the global partnerships focused on improving access to medicine for both COVID-19 and other diseases, noting the increased threat of antibiotic resistance.
The article then underlines the positive action of eight pharmaceutical companies to pair their pipeline with access strategies to increase post-launch access to medicine, albeit these are mostly aimed at middle-income countries.
Read the full article here.